Go to ...

Nordens Ekonomi Norge

RSS Feed

21. november 2018

Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stroke Demonstrated in REDUCE-IT™ Supports 25% Overall Reduction in Five-Point Major Adverse Cardiovascular Event Primary Composite E


Euroinvestor.com A/S Euroinvestor.com A/S



Landmark Cardiovascular Risk Reduction Benefits Demonstrated in REDUCE-IT Are Largest of Any Major Cardiovascular Outcomes Study of a Drug Intended to Address Residual Cardiovascular Risk Remaining After Cholesterol Management


More Stories From

Do NOT follow this link or you will be banned from the site!
Read previous post:
Oljefondet foretrekker dollar, euro og pund: Ekspertene fraråder grepet

I fjor foreslo Oljefondet å begrense seg til å eie statsgjeld i dollar, euro og pund. En ekspertgruppe mener at...

Close